{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:28:00Z","timestamp":1791390480694,"version":"4.3.3"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/nrl.0b013e31815cffae","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T07:15:14Z","timestamp":1210058114000},"page":"143-150","source":"Crossref","is-referenced-by-count":62,"title":["Clinical Epidemiology of Atrial Fibrillation and Related Cerebrovascular Events in the United States"],"prefix":"10.1097","volume":"14","author":[{"given":"Kamakshi","family":"Lakshminarayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan I.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210211","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text. A report of the American college of Cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European heart rhythm association and the heart rhythm society.","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"R2-1-20210211","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"R3-1-20210211","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","article-title":"Epidemiology and natural history of atrial fibrillation: clinical implications.","volume":"37","author":"Chugh","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R4-1-20210211","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002).","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"R5-1-20210211","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9149(94)90363-8","article-title":"Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study).","volume":"74","author":"Furberg","year":"1994","journal-title":"Am J Cardiol"},{"key":"R6-1-20210211","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics-2007 update: a report from the american heart association statistics committee and stroke statistics subcommittee.","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"key":"R7-1-20210211","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4065\/71.2.150","article-title":"Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment.","volume":"71","author":"Blackshear","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R8-1-20210211","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"R9-1-20210211","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"R10-1-20210211","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0002-8703(96)90288-4","article-title":"Secular trends in the prevalence of atrial fibrillation: the Framingham study.","volume":"131","author":"Wolf","year":"1996","journal-title":"Am Heart J"},{"key":"R11-1-20210211","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0735-1097(03)00500-X","article-title":"The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades.","volume":"42","author":"Tsang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R13-1-20210211","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults.","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"R14-1-20210211","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study.","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"R15-1-20210211","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"R16-1-20210211","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R17-1-20210211","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.amjcard.2004.04.068","article-title":"Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001.","volume":"94","author":"Khairallah","year":"2004","journal-title":"Am J Cardiol"},{"key":"R18-1-20210211","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-5273(01)00626-X","article-title":"Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986\u20131995.","volume":"82","author":"Stewart","year":"2002","journal-title":"Int J Cardiol"},{"key":"R19-1-20210211","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.eupc.2004.01.004","article-title":"Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow-up.","volume":"6","author":"Hoogsteen","year":"2004","journal-title":"Europace"},{"key":"R20-1-20210211","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(84)91109-7","article-title":"Atrial fibrillation in healthy non-alcoholic people after an alcoholic binge.","volume":"2","author":"Thornton","year":"1984","journal-title":"Lancet"},{"key":"R21-1-20210211","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0002-8703(78)90296-X","article-title":"Arrhythmias and the \u201choliday heart\u201d: alcohol-associated cardiac rhythm disorders.","volume":"95","author":"Ettinger","year":"1978","journal-title":"Am Heart J"},{"key":"R22-1-20210211","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/01.CIR.94.3.390","article-title":"Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources.","volume":"94","author":"Aranki","year":"1996","journal-title":"Circulation"},{"key":"R23-1-20210211","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJM199207093270206","article-title":"Thyrotoxicosis and the heart.","volume":"327","author":"Woeber","year":"1992","journal-title":"N Engl J Med"},{"key":"R24-1-20210211","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation (see comment).","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"R25-1-20210211","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000087636","article-title":"The association of metabolic syndrome with atrial fibrillation: an emerging epidemiological and pathophysiological hypothesis.","volume":"104","author":"Korantzopoulos","year":"2005","journal-title":"Cardiology"},{"key":"R26-1-20210211","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1093\/eurheartj\/sui014","article-title":"The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors.","volume":"7S","author":"Gersh","year":"2005","journal-title":"Eur Heart J"},{"key":"R27-1-20210211","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/01.CIR.0000118535.15205.8F","article-title":"Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study.","volume":"109","author":"Eaker","year":"2004","journal-title":"Circulation"},{"key":"R29-1-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.104.1.19","article-title":"Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey.","volume":"104","author":"McGovern","year":"2001","journal-title":"Circulation"},{"key":"R30-1-20210211","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00006454-199110001-00006","article-title":"Current status of nonsuppurative complications of group A streptococci.","volume":"10","author":"Dajani","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R31-1-20210211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.hco.0000198985.78508.55","article-title":"Management of atrial fibrillation in rheumatic valvular heart disease.","volume":"21","author":"Vora","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"R32-1-20210211","first-page":"e154","article-title":"ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society For Heart And Lung Transplantation: endorsed by the Heart Rhythm Society.","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"R33-1-20210211","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.nutr.23.011702.073349","article-title":"Secular trends in dietary intake in the united states.","volume":"24","author":"Briefel","year":"2004","journal-title":"Annu Rev Nutr"},{"key":"R34-1-20210211","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.HYP.0000142248.54761.56","article-title":"The burden of adult hypertension in the United States 1999 to 2000: a rising tide (see comment).","volume":"44","author":"Fields","year":"2004","journal-title":"Hypertension"},{"key":"R35-1-20210211","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000.","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"R36-1-20210211","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease.","volume":"105","author":"Movahed","year":"2005","journal-title":"Int J Cardiol"},{"key":"R37-1-20210211","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"R38-1-20210211","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study.","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"R39-1-20210211","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"R40-1-20210211","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"R41-1-20210211","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0002-9343(91)90008-L","article-title":"Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study.","volume":"91","author":"Moulton","year":"1991","journal-title":"Am J Med"},{"key":"R42-1-20210211","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/0003-4819-128-8-199804150-00004","article-title":"Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in left atrial thrombi.","volume":"128","author":"Stollberger","year":"1998","journal-title":"Ann Intern Med"},{"key":"R43-1-20210211","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"key":"R44-1-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/WNL.46.1.159","article-title":"Silent brain infarction in nonrheumatic atrial fibrillation. EAFT study group. European atrial fibrillation trial.","volume":"46","year":"1996","journal-title":"Neurology"},{"key":"R45-1-20210211","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"R46-1-20210211","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. analysis of pooled data from five randomized controlled trials.","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"R47-1-20210211","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","article-title":"Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials.","volume":"158","year":"1998","journal-title":"Arch Intern Med"},{"key":"R48-1-20210211","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-128-8-199804150-00005","article-title":"Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography.","volume":"128","year":"1998","journal-title":"Ann Intern Med"},{"key":"R49-1-20210211","first-page":"15","article-title":"Echocardiographic and hematological variables as a risk factor for stroke in chronic nonvalvular atrial fibrillation.","volume":"32","author":"Uzui","year":"1998","journal-title":"J Cardiol"},{"key":"R50-1-20210211","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0735-1097(98)00146-6","article-title":"Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators.","volume":"31","author":"Zabalgoitia","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R51-1-20210211","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01148951","article-title":"Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation.","volume":"11","author":"Mitusch","year":"1995","journal-title":"Int J Card Imaging"},{"key":"R52-1-20210211","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9149(97)00854-0","article-title":"Association of mitral annular calcium with new thromboembolic stroke at 44-month follow-up of 2,148 persons, mean age 81 years.","volume":"81","author":"Aronow","year":"1998","journal-title":"Am J Cardiol"},{"key":"R53-1-20210211","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9149(98)00247-1","article-title":"Risk factors for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillation.","volume":"82","author":"Aronow","year":"1998","journal-title":"Am J Cardiol"},{"key":"R54-1-20210211","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00127893-199809000-00001","article-title":"Atrial fibrillation and stroke: epidemiology, pathophysiology and management.","volume":"4","author":"Anderson","year":"1998","journal-title":"Neurologist"},{"key":"R55-1-20210211","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-138-10-200305200-00011","article-title":"Lessons from the stroke prevention in atrial fibrillation trials.","volume":"138","author":"Hart","year":"2003","journal-title":"Ann Intern Med"},{"key":"R56-1-20210211","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) study group.","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"R57-1-20210211","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators.","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"R58-1-20210211","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"R59-1-20210211","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation.","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"R60-1-20210211","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1052-3057(10)80166-1","article-title":"Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the stroke prevention in atrial fibrillation study.","volume":"5","year":"1995","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R61-1-20210211","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","article-title":"Antithrombotic therapy in atrial fibrillation.","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"R62-1-20210211","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"R63-1-20210211","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","article-title":"Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: stroke prevention in atrial fibrillation III study. The SPAF III writing committee for the stroke prevention in atrial fibrillation investigators.","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"R64-1-20210211","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"key":"R65-1-20210211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9343(00)00440-X","article-title":"Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.","volume":"109","author":"Pearce","year":"2000","journal-title":"Am J Med"},{"key":"R66-1-20210211","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1525-1497.1999.00281.x","article-title":"Stroke risk in an elderly population with atrial fibrillation.","volume":"14","author":"Feinberg","year":"1999","journal-title":"J Gen Intern Med"},{"key":"R67-1-20210211","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review.","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"R68-1-20210211","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.STR.0000181115.59173.42","article-title":"Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.","volume":"36","author":"Arima","year":"2005","journal-title":"Stroke"},{"key":"R69-1-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.160.1.41","article-title":"Why do patients with atrial fibrillation not receive warfarin?","volume":"160","author":"Bungard","year":"2000","journal-title":"Arch Intern Med"},{"key":"R70-1-20210211","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.158.19.2093","article-title":"Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation.","volume":"158","author":"Brass","year":"1998","journal-title":"Arch Intern Med"},{"key":"R71-1-20210211","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/01.STR.0000185927.63746.23","article-title":"Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study.","volume":"36","author":"Miyasaka","year":"2005","journal-title":"Stroke"},{"key":"R72-1-20210211","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.STR.26.8.1471","article-title":"Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.","volume":"26","author":"Hart","year":"1995","journal-title":"Stroke"},{"key":"R73-1-20210211","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin.","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"key":"R74-1-20210211","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archinte.1996.00440040081009","article-title":"Bleeding during antithrombotic therapy in patients with atrial fibrillation. The stroke prevention in atrial fibrillation investigators.","volume":"156","year":"1996","journal-title":"Arch Intern Med"},{"key":"R75-1-20210211","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","article-title":"Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy.","volume":"87","author":"Landefeld","year":"1989","journal-title":"Am J Med"},{"key":"R76-1-20210211","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/01.wnl.0000250340.05202.8b","article-title":"The increasing incidence of anticoagulant-associated intracerebral hemorrhage.","volume":"68","author":"Flaherty","year":"2007","journal-title":"Neurology"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NRL.0b013e31815cffae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:40:36Z","timestamp":1620967236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-200805000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e31815cffae","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}